• AlzeCure's abstract on ACD856's anti-inflammatory effects to be presented at a leading Alzheimer's conference

  • AlzeCure Pharma broadcasts live event about the phase II candidate ACD440 against neuropathic pain

  • AlzeCure Pharma's CEO Martin Jönsson to present at Redeye's Neurology Day

AlzeCure Pharma

AlzeCure Pharma is a Swedish pharmaceutical company focusing on the research and development of innovative and efficacious treatments for Alzheimer’s disease and related disorders

Research

AlzeCure is developing disease modifying and symptomatic first in class treatments for Alzheimer’s disease and other conditions characterized by cognitive dysfunction

Alzheimer’s Disease

Alzheimer’s disease is a deadly disorder which lacks effective treatments. The need for novel treatments is therefore urgent.